Compare DexCom, Inc. (DXCM) vs PepsiCo, Inc. (PEP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs PepsiCo, Inc. — how do they compare? DexCom, Inc. trades at $84.11 (market cap $31.86B), while PepsiCo, Inc. trades at $125.97 (market cap $174.89B). The key difference: PepsiCo, Inc. is far larger — about 5.5× DexCom, Inc.'s market cap, and PepsiCo, Inc. pays a 4.61% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold DexCom, Inc. for 62 Days and PepsiCo, Inc. for 107 Days on average.
| DXCM | PEP | |
|---|---|---|
Market Cap | $31.86B | $174.89B |
Volume | 3,607,070 | 23,968,864 |
Sector | Health | Consumer Staples |
52-Week High | $92.34 | $170.44 |
52-Week Low | $54.84 | $123.64 |
Typical Hold Time | 62 Days | 107 Days |
Enterprise Value | $31.32B | $215.61B |
Dividend Yield | — | 4.61% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DexCom (DXCM) trades at $84.41, showing modest daily gains of 0.13%. The stock demonstrates strong fundamental performance with consistent earnings beats and robust revenue growth, reaching $4.66 billion in 2025. Technical indicators show a bearish short-term trend with key support at $82. The company maintains impressive profitability with 20.12% net margins and 38.49% ROE, supported by growing adoption of CGM technology in diabetes care.
DXCM presents a compelling growth story with expanding market opportunities in Type 2 diabetes care. Analyst consensus remains strongly bullish with 81% buy ratings and $95.07 price target, suggesting 13% upside. Key risks include reimbursement challenges and competitive pressures. The company's strong cash flow generation and institutional support provide solid foundation for continued growth.
PepsiCo (PEP) trades at $128.88, up 4.24% with strong earnings momentum as the company has beaten EPS estimates for four consecutive quarters. The stock shows bearish technical signals but maintains solid fundamentals with 10.78% net income margin and 51.59% ROE. Recent news highlights price adjustments for snack products and sponsorship changes, while analysts maintain a consensus price target of $146.77 representing 13.9% upside potential from current levels.
PepsiCo presents a mixed investment case with strong profitability metrics and consistent earnings beats offset by bearish technical indicators and margin pressure from recent price cuts. The company's stable cash flow generation and dividend payments provide downside protection, though competitive pressures and consumer resistance to higher prices remain key risks. Wall Street sentiment leans cautious with 67.4% hold ratings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About PepsiCo, Inc.
PepsiCo is one of the largest food and beverage companies globally. It makes, markets, and sells a slew of brands across the beverage and snack categories, including Pepsi, Mountain Dew, Gatorade, Doritos, Lays, and Ruffles. The firm uses a largely integrated go-to-market model, though it does leverage third-party bottlers, contract manufacturers, and distributors in certain markets. In addition to company-owned trademarks, Pepsi manufactures and distributes other brands through partnerships and joint ventures with companies such as Starbucks. The firm segments its operations into five primary geographies, with North America (comprising Frito-Lay North America, Quaker Foods North America, and North America beverages) constituting around 60% of consolidated revenue.
Read more on PEP →
